🇺🇸 FDA
Patent

US 11066433

Pentaaza macrocyclic ring complexes possessing oral bioavailability

granted A61KA61K31/28A61K31/555

Quick answer

US patent 11066433 (Pentaaza macrocyclic ring complexes possessing oral bioavailability) held by Galera Labs, LLC expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Galera Labs, LLC
Grant date
Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/28, A61K31/555, A61K47/14, A61K47/38